You are here

Sertoli Treated Cord Blood for Spinal Cord Injury

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43NS050065-01
Agency Tracking Number: NS050065
Amount: $150,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
3650 Spectrum Blvd. UTC II, Suite 170
TAMPA, FL 33612
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 CYNDY Davis
 (813) 866-6372
 CDH@SANERON-CCEL.COM
Business Contact
 NICOLE KUZMIN-NICHOLS
Phone: (813) 866-6371
Email: NKN@SANERON-CCEL.COM
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): Stem cells from human umbilical cord blood (hUCB) represent a promising cellular therapeutic strategy for the treatment of cord injury (SCI). These cells are capable of differentiating into neurons and glia in vivo

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government